# Personalized Treatment for Refractory H Pylori Infection

> **NCT02547025** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 126 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** rabeprazole+3 antibiotics
- **DRUG:** rabeprazole+bismuth+2 antibiotics
- **DRUG:** rabeprazole+amox+tetr+levo

## Key facts

- **NCT ID:** NCT02547025
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02547025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02547025, "Personalized Treatment for Refractory H Pylori Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02547025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*